174 related articles for article (PubMed ID: 11709569)
1. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
[TBL] [Abstract][Full Text] [Related]
3. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
Sorensen JM; Vena DA; Fallavollita A; Chun HG; Cheson BD
J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
Hiddemann W; Rottmann R; Wörmann B; Thiel A; Essink M; Ottensmeier C; Freund M; Büchner T; van de Loo J
Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
Pillay GS; Wood L; Jacobs P
S Afr Med J; 1996 Aug; 86(8):949-51. PubMed ID: 8823419
[TBL] [Abstract][Full Text] [Related]
8. The bioavailability of oral fludarabine phosphate is unaffected by food.
Oscier D; Orchard JA; Culligan D; Cunningham D; Johnson S; Parker A; Klein M; Gieschen H
Hematol J; 2001; 2(5):316-21. PubMed ID: 11920267
[TBL] [Abstract][Full Text] [Related]
9. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
Puccio CA; Mittelman A; Lichtman SM; Silver RT; Budman DR; Ahmed T; Feldman EJ; Coleman M; Arnold PM; Arlin ZA
J Clin Oncol; 1991 Sep; 9(9):1562-9. PubMed ID: 1714949
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Solal-Céligny P; Brice P; Brousse N; Caspard H; Bastion Y; Haïoun C; Bosly A; Tilly H; Bordessoule D; Sebban C; Harousseau JL; Morel P; Dupas B; Plassart F; Vasile N; Fort N; Leporrier M
J Clin Oncol; 1996 Feb; 14(2):514-9. PubMed ID: 8636765
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Keating MJ; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs CC; Freireich EJ; McCredie KB
J Clin Oncol; 1991 Jan; 9(1):44-9. PubMed ID: 1702145
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
Schulz H; Klein SK; Rehwald U; Reiser M; Hinke A; Knauf WU; Aulitzky WE; Hensel M; Herold M; Huhn D; Hallek M; Diehl V; Engert A;
Blood; 2002 Nov; 100(9):3115-20. PubMed ID: 12384407
[TBL] [Abstract][Full Text] [Related]
13. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.
Decaudin D; Bosq J; Tertian G; Nedellec G; Bennaceur A; Venuat AM; Bayle C; Carde P; Bendahmane B; Hayat M; Munck JN
J Clin Oncol; 1998 Feb; 16(2):579-83. PubMed ID: 9469344
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response.
Angelopoulou MA; Poziopoulos C; Boussiotis VA; Kontopidou F; Pangalis GA
Leuk Lymphoma; 1996 Apr; 21(3-4):321-4. PubMed ID: 8726414
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T
J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
Foran JM; Oscier D; Orchard J; Johnson SA; Tighe M; Cullen MH; de Takats PG; Kraus C; Klein M; Lister TA
J Clin Oncol; 1999 May; 17(5):1574-9. PubMed ID: 10334546
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral fludarabine in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Zhu Y; Qin Q; Xie Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 38(3):221-4. PubMed ID: 23545817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
